Footshock-Induced Urinary Bladder Hypersensitivity: Role of Spinal Corticotropin-Releasing Factor Receptors

Journal of Pain

Volumn 9, Issue 11, 2008, Pages 991-998

  Robbins, Meredith T ^a   Ness, Timothy J ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

corticotropin releasing factor; hypersensitivity; Urinary bladder; urocortin; visceral

Indexed keywords

ANTALARMIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; NEUROPEPTIDE; PROTEIN INHIBITOR; UROCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER DISTENSION; CONTROLLED STUDY; CYSTALGIA; DISEASE EXACERBATION; FEMALE; FOOTSHOCK; HYPERALGESIA; HYPERSENSITIVITY; NOCICEPTION; NONHUMAN; PROTEIN FUNCTION; RAT; SPINAL CORD; STRESS;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; ELECTROMYOGRAPHY; ELECTROSHOCK; FEMALE; FOOT; INJECTIONS, SPINAL; PEPTIDE FRAGMENTS; PYRIMIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SPINAL CORD; STRESS, PSYCHOLOGICAL; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; UROCORTINS; URODYNAMICS;

EID: 54449096240     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2008.05.006     Document Type: Article

References (58)

1. Amit Z., and Galina Z.H. Stress-induced analgesia: Adaptive pain suppression. Physiol Rev 66 (1986) 1091-1120
2. Anderson R.H., Ness T.J., and Gebhart G.F. A distension control device used for quantitative studies of hollow organ sensation. Physiol Behav 41 (1988) 635-638
3. Baldoni F., Ercolani M., Baldaro B., and Trombini G. Stressful events and psychological symptoms in patients with functional urinary disorders. Percept Mot Skills 80 (1995) 605-606
4. Bittencourt J.C., Vaughn J., Arias C., Rissman R.A., Vale W.W., and Sawchenko P.E. Urocortin expression in rat brain: Evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol 415 (1999) 285-312
5. Castroman P., and Ness T.J. Vigor of visceromotor responses to urinary bladder distension in rats increases with repeated trials and stimulus intensity. Neurosci Lett 306 (2001) 97-100
6. Dancey M., Taghavi C.P., and Fox R.J. The relationship between daily stress and symptoms of irritable bowel. J Psychosom Res 44 (1998) 537-545
7. Donaldson C.J., Sutton S.W., Perrin M.H., Corrigan A.Z., Lewis K.A., Rivier J.E., Vaughan J.M., and Vale W.W. Cloning and characterization of human urocortin. Endocrinology 137 (1996) 2167-2170
8. Farber E.M., Nickoloff B.J., Recht B., and Fraki J.E. Stress, symmetry and psoriasis: Possible role of neuropeptides. Am J Acad Dermatol 2 (1986) 305
9. Fukudo S., Nomura T., and Hongo M. Impact of corticotropin releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 42 (1998) 845-849
10. Garrett V.D., Brantley P.J., Jones G.N., and McKnight G.T. The relation between daily stress and Crohn's disease. J Behav Med 14 (1991) 87-96
11. Greenwood-van Meerveld B., Johnson A.C., Cochrane S., Schulkin J., and Myers D.A. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterol Motil 17 (2005) 415-422
12. Henry B., Vale W., and Markou A. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress. J Neurosci 26 (2006) 9142-9152
13. Imaki T., Nahan J.L., and Rivier C. Differential regulation of corticotrophin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J Neurosci 11 (1991) 585-599
14. Kant G.J., Mougey E.H., Pennington L.L., and Meyerhoff J.L. Graded footshock stress elevates pituitary cyclic AMP and plasma β-endorphin, β-LPH, corticosterone and prolactin. Life Sci 33 (1983) 2657-2663
15. Kempuraj D., Papadopoulou N.G., Lytinas M., Huang M., Kandere-Grzybowska K., Madhappan B., Boucher W., Christodoulou S., Athanassiou A., and Theoharides T.C. Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology 145 (2004) 43-48
16. Kempuraj D., Papadopoulou N.G., Stanford E.J., Christodoulou S., Madhappan B., Sant G.R., Solage K., Adams T., and Theoharides T.C. Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin. Am J Reprod Immunol 52 (2004) 267-275
17. Kidoo D.A., Valentino R.J., Zderic S., Ganesh A., Leiser S.C., Hale L., and Grigoriadis D.E. Impact of state of arousal and stress neuropeptides on urodynamic function in freely moving rats. Am J Physiol Regul Integr Comp Physiol 290 (2006) R1697-R1706
18. Klausner A.P., Streng T., Na Y.G., Raju J., Batts T.W., Tuttle J.B., Andersson K.E., and Steers W.D. The role of corticotrophin releasing factor and its antagonist, astressin, on micturition in the rat. Auton Neurosci 123 (2005) 26-35
19. Kozicz T., Yanaihara H., and Arimura A. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol 391 (1998) 1-10
20. Koziol J.A., Clark D.C., Gittes R.F., and Tan E.M. The natural history of interstitial cystitis: A survey of 374 patients. J Urol 149 (1993) 465-469
21. LaBerge J., Malley S.E., Zvarova K., and Vizzard M.A. Expression of corticotrophin-releasing factor and CRF receptors in micturition pathways after cyclophosphamide-induced cystitis. Am J Physiol Regul Integr Comp Physiol 291 (2006) R692-R703
22. Ledaris K., Letter A., McMaster D., Moore G., and Schlesinger D. Complete amino acid sequence of urotensin I, a hypotensive and corticotrophin-releasing neuropeptide from Catostomus. Science 218 (1982) 162-164
23. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., Vaughan J., Reyes T.M., Gulyas J., Fischer W., Bilezikjian L., Rivier J., Sawchenko P.E., and Vale W.W. Identification of urocortin III, an additional member of the corticotrophin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A 98 (2001) 7570-7575
24. Li C., Vaughan J., Sawchenko P.E., and Vale W.W. Urocortin III-immunoreactive projections in rat brain: Partial overlap with sites of type 2 corticotropin-releasing factor receptor expression. J Neurosci 22 (2002) 991-1001
25. Lutgendorf S.K., Kreder K.J., Rothrock N.E., Ratliff T.L., and Zimmerman B. Stress and symptomatology in patients with interstitial cystitis: A laboratory stress model. J Urol 164 (2000) 1265-1269
26. Macaulay A.J., Stern R.S., Holmes D.M., and Santon S.L. Micturition and the mind: Psychological factors in the etiology and treatment of urinary symptoms in women. Br Med J 294 (1987) 540-543
27. Maier S.F., and Watkins L.R. Stressor controllability and learned helplessness: The roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci Biobehav Rev 29 (2005) 829-841
28. Mano-Otagiri A., and Shibasaki T. Distribution of urocortin 2 and urocortin 3 in rat brain. J Nippon Med Sch 71 (2004) 358-359
29. Million M., Wang L., Stenzel-Poore M.P., Coste S.C., Yaun P.Q., Lamy C., Rivier J., Buffington T., and Taché Y. Enhanced pelvic responses to stressors in female CRF-overexpressing mice. Am J Physiol Regul Integr Comp Physiol 292 (2006) R1429-R1438
30. Montecucchi P.C., and Henschen A. Amino acid composition and sequence analysis of sauvagine, a new active peptide from the skin of Phyllomedusa sauvagei. Int J Peptide Protein Res 18 (1981) 113-120
31. Nijsen M., Ongenae N., Meukemans A., and Coulie B. Divergent role for CRF1 and CRF2 receptors in the modulation of visceral pain. Neurogastroenterol Motil 17 (2005) 423-432
32. Owens M.J., and Nereroff C.B. Physiology and pharmacology of corticotrophin-releasing factor. Pharmacol Rev 43 (1991) 425-474
33. Pavcovich L.A., and Valentino R.J. Central regulation of micturition in the rat by the corticotrophin-releasing hormone from Barrington's nucleus. Neurosci Lett 196 (1995) 185-188
34. Perrin M.H., and Vale W.W. Corticotropin releasing factor receptors and their ligand family. Ann NY Acad Sci 885 (1999) 312-328
35. Puder B.A., and Papka R.E. Distribution and origin of corticotrophin-releasing factor-immunoreactive axons in the female rat lumbosacral spinal cord. J Neurosci Res 66 (2001) 1217-1225
36. Randich A., Uzzell T., Cannon R., and Ness T.J. Inflammation and enhanced nociceptive responses to bladder distension produced by intravesical zymosan in the rat. BMC Urol 6 (2006) 2-8
37. Reyes T.M., Lewis K., Perrin M.H., Kunitake K., Vaughan J., Arias C.A., Hogenesch J.B., Gulyas J., Rivier J., Sawchenko P.E., and Vale W.W. Urocortin II: A member of the corticotrophin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 receptors. Proc Natl Acad Sci U S A 98 (2001) 2843-2848
38. Rivier C., and Vale W. Diminished responsiveness of the hypothalamic-pituitary-adrenal axis of the rat during exposure to prolonged stress: A pituitary-mediated mechanism. Endocrinology 121 (1987) 1320-1328
39. Robbins M.T., DeBerry J., and Ness T.J. Chronic psychological stress enhances nociceptive processing in the urinary bladder in high-anxiety rats. Physiol Behav 91 (2007) 544-550
40. Rothrock N.E., Lutgendorf S.K., Kreder K.J., Ratliff T.L., and Zimmerman B. Daily stress and symptom exacerbation in interstitial cystitis patients. Urology 57 (2001) 422-427
41. Sajdyk T.J., Schober D.A., Gehlert D.R., and Shekhar A. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res 100 (1999) 207-215
42. Sagami Y., Shimada Y., Tayama J., Nomura T., Satake M., Endo Y., Shoji T., Karahashi K., Hongo M., and Fukudo S. Effect of a corticotropin-releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 53 (2004) 958-964
43. Saito K., Kasai T., Nagura Y., Ito H., Kanazawa M., and Fukudo S. Corticotropin-releasing hormone receptor-1 antagonist blocks brain-gut activation induced by colonic distension in rats. Gastroenterology 129 (2005) 1533-1543
44. Schwetz I., Bradesi S., McRoberts J.A., Sablad M., Miller J.C., Zhou H., Ohning G., and Mayer E.A. Delayed stress-induced colonic hypersensitivity in male Wistar rats: Role of neurokinin-1 and corticotropin-releasing factor-1 receptors. Am J Physiol Gastrointest Liver Physiol 286 (2004) G683-G691
45. Singh L.K., Boucher W., Pang X., Letourneau R., Seretakis D., Green M., and Theoharides T.C. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. J Pharmacol Exp Ther 288 (1999) 1349-1356
46. Tanaka Y., Makino S., Noguchi T., Tamura K., Kaneda T., and Hashimoto K. Effects of stress and adrenalectomy on urocortin II mRNA expression in the hypothalamic paraventricular nucleus of the rat. Neuroendocrinology 78 (2003) 1-11
47. Theoharides T.C., Donelan J.M., Papadopoulou N., Cao J., Kempuraj D., and Conti P. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci 25 (2004) 563-568
48. Thomason B.T., Brantley P.J., Jones G.N., Dyer H.R., and Morris J.L. The relation between stress and disease activity in rheumatoid arthritis. J Behav Med 15 (1992) 215-220
49. Trimble N., Johnson A.C., Foster A., and Greenwood van-Meerveld B. Corticotropin-releasing factor receptor 1-deficient mice show decreased anxiety and colonic sensitivity. Neurogastroenterol Motil 19 (2007) 754-760
50. Uzuki M., Sasano H., Muramatsu Y., Totsune K., Takahashi K., Oki Y., Iino K., and Sawai T. Urocortin in the synovial tissue of patients with rheumatoid arthritis. Clin Sci 100 (2001) 577-589
51. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Rivier J., Sawchenko P.E., and Vale W.W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotrophin-releasing factor. Nature 378 (1995) 287-292
52. Venihaki M., Sakihara S., Subraminian S., Dikkes P., Weninger S.C., Liapakis G., Graf T., and Majzoub J.A. Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: Modulation by stress and attenuation of some anxiety-like behaviors. J Neuroendocrinol 16 (2004) 411-422
53. Watkins L.R., Cobelli D.A., and Mayer D.J. Opiate vs non-opiate footshock induced analgesia (FSIA): Descending and intraspinal components. Brain Res 245 (1982) 97-106
54. Weninger S.C., Peters L.L., and Majzoub J.A. Urocortin expression in the Edinger-Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency. Endocrinology 141 (2000) 256-263
55. Wu Y., Xu Y., Zhou H., Tao J., and Li S. Expression of urocortin in rat lung and its effect on pulmonary vascular permeability. J Endocrinol 189 (2006) 167-178
56. Wu Y., Zhou H., Xu Y., and Li S. Enhanced expression of urocortin in lung tissues of rats with allergic asthma. Biochem Biophys Res Commun 341 (2006) 532-540
57. Young E., and Akil H. Changes in releasability of ACTH and beta-endorphin with chronic stress. Neuropeptides 5 (1985) 545-548
58. Zautra A.J., Hoffman J., Potter P., Matt K.S., Yocum D., and Castro L. Examination of changes in interpersonal stress as a factor in disease exacerbations among women with rheumatoid arthritis. Ann Behav Med 19 (1997) 279-286